Cardiology

RELAX-AHF shows first positive findings in HFpEF patients

Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced (HFrEF) during the first 24 hours, according to results from RELAX-AHF presented in today's late ...

Cardiology

Diltiazem relieves capecitabine-induced chest pain

(HealthDay)—Secondary prophylaxis with diltiazem may offer cancer patients relief from capecitabine-induced chest pain and dyspnea and allow them to tolerate capecitabine treatment, according to a study published in the ...

Oncology & Cancer

Unsuspected PE seldom linked to death in cancer patients

(HealthDay)—Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published in the October ...

Cardiology

Peptide level ups diagnosis of heart failure in primary care

(HealthDay) -- For patients presenting with dyspnea, the additional measurement of B-type natriuretic peptide (BNP) levels increases the certainty of diagnosis of heart failure and accelerates initiation of appropriate treatment, ...

page 1 from 3

Dyspnea

Dyspnea ( /dɪspˈniːə/ disp-nee; also dyspnoea; Latin: dyspnoea; Greek: δύσπνοια, dýspnoia), shortness of breath (SOB), or air hunger, is the subjective symptom of breathlessness.

It is a normal symptom of heavy exertion but becomes pathological if it occurs in unexpected situations. In 85% of cases it is due to either asthma, pneumonia, cardiac ischemia, interstitial lung disease, congestive heart failure, chronic obstructive pulmonary disease, or psychogenic causes. Treatment typically depends on the underlying cause.

This text uses material from Wikipedia, licensed under CC BY-SA